Edesa Biotech, Inc. (EDSA)
2.74
-0.08
(-2.84%)
USD |
NASDAQ |
Oct 21, 16:00
2.74
0.00 (0.00%)
After-Hours: 19:15
Edesa Biotech EPS Diluted (Quarterly) : -0.6003 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.6003 |
| March 31, 2026 | -0.4939 |
| December 31, 2025 | -0.2819 |
| September 30, 2025 | -0.3157 |
| June 30, 2025 | -0.2491 |
| March 31, 2025 | -0.2998 |
| December 31, 2024 | -0.4835 |
| September 30, 2024 | -0.2962 |
| June 30, 2024 | -0.5178 |
| March 31, 2024 | -0.583 |
| December 31, 2023 | -0.5366 |
| September 30, 2023 | -0.0799 |
| June 30, 2023 | -0.0967 |
| March 31, 2023 | -0.1169 |
| December 31, 2022 | -0.127 |
| September 30, 2022 | -0.1689 |
| June 30, 2022 | -0.3743 |
| March 31, 2022 | -0.3295 |
| December 31, 2021 | -0.3279 |
| September 30, 2021 | -0.278 |
| June 30, 2021 | -0.3591 |
| March 31, 2021 | -0.1941 |
| December 31, 2020 | -0.2566 |
| September 30, 2020 | -0.2194 |
| June 30, 2020 | -0.1993 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.1704 |
| December 31, 2019 | -0.1458 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | -1.864 |
| December 31, 2018 | -1.582 |
| September 30, 2018 | -1.271 |
| June 30, 2018 | -2.28 |
| March 31, 2018 | -5.400 |
| December 31, 2017 | -5.46 |
| September 30, 2017 | -4.874 |
| June 30, 2017 | -5.04 |
| March 31, 2017 | -4.62 |
| December 31, 2016 | -6.30 |
| September 30, 2016 | -5.46 |
| June 30, 2016 | -5.88 |
| March 31, 2016 | -4.20 |
| December 31, 2015 | -7.98 |
| September 30, 2015 | -7.98 |
| June 30, 2015 | 4.20 |
| March 31, 2015 | -4.20 |
| December 31, 2014 | -8.40 |
| August 31, 2014 | -24.87 |
| May 31, 2014 | 8.40 |
| February 28, 2014 | -1.331 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ProMIS Neurosciences, Inc. | -1.283 |
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.408M |
| Total Expenses (Quarterly) | 5.408M |
| Enterprise Value | 25.25M |
| Earnings Yield | -61.74% |
| Normalized Earnings Yield | -63.47 |